Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2018 Apr 20

PMID 29671805

Citations 46

Authors

Mauricio Arias

Kathlyn B Piga

M Eric Hyndman

Hans J Vogel

Affiliations

Soon will be listed here.

Abstract

Antimicrobial peptides (AMPs) constitute a promising alternative for the development of new antibiotics that could potentially counteract the growing number of antibiotic-resistant bacteria. However, the AMP structure⁻function relationships remain unclear and detailed studies are still necessary. The positively charged amino acid residues (Arg and Lys) play a crucial role in the activity of most AMPs due to the promotion of electrostatic interactions between the peptides and bacterial membranes. In this work we have analyzed the antimicrobial and structural properties of several Trp-rich AMPs containing exclusively either Arg or Lys as the positively charged residues. Their antimicrobial activity and mechanism of action were investigated, showing that Lys residues give rise to a reduced antimicrobial potency for most peptides, which was correlated, in turn, with a decrease in their ability to permeabilize the cytoplasmic membrane of . Additionally, the presence of Arg and Lys renders the peptides susceptible to degradation by proteases, such as trypsin, limiting their therapeutic use. Therefore, modifications of the side chain length of Arg and Lys were investigated in an attempt to improve the protease resistance of AMPs. This approach resulted in enhanced stability to trypsin digestion, and in several cases, shorter sidechains conserved or even improved the antimicrobial activity. All together, these results suggest that Arg-to-Lys substitutions, coupled with side chain length modifications, can be extremely useful for improving the activity and stability of AMPs.

Citing Articles

Antibiofilm Activities of Tritrpticin Analogs Against Pathogenic PA01 Strains.

Ramamourthy G, Ishida H, Vogel H Molecules. 2025; 30(4).

PMID: 40005137 PMC: 11858513. DOI: 10.3390/molecules30040826.

Self-Assembled Peptide Hydrogels PPI45 and PPI47: Novel Drug Candidates for Infection Treatment.

Wu Q, Deng M, Mao R, Yang N, Hao Y, Cao M Gels. 2025; 11(1).

PMID: 39852034 PMC: 11764660. DOI: 10.3390/gels11010063.

Antimicrobial Peptides: Mechanism, Expressions, and Optimization Strategies.

Miao H, Wang L, Wu Q, Huang Z Probiotics Antimicrob Proteins. 2024; .

PMID: 39528853 DOI: 10.1007/s12602-024-10391-4.

Dimerization and lysine substitution of melittin have differing effects on bacteria.

Matthyssen T, Li W, Holden J, Lenzo J, Hadjigol S, OBrien-Simpson N Front Pharmacol. 2024; 15:1443497.

PMID: 39434904 PMC: 11492869. DOI: 10.3389/fphar.2024.1443497.

Exploring a Potential Optimization Route for Peptide Ligands of the Sam Domain from the Lipid Phosphatase Ship2.

Vincenzi M, Mercurio F, La Manna S, Palumbo R, Pirone L, Marasco D Int J Mol Sci. 2024; 25(19).

PMID: 39408946 PMC: 11476629. DOI: 10.3390/ijms251910616.

References

Bagheri M, Arasteh S, Haney E, Hancock R . Tryptic Stability of Synthetic Bactenecin Derivatives Is Determined by the Side Chain Length of Cationic Residues and the Peptide Conformation. J Med Chem. 2016; 59(7):3079-86. DOI: 10.1021/acs.jmedchem.5b01740. View

Chin W, Zhong G, Pu Q, Yang C, Lou W, de Sessions P . A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset. Nat Commun. 2018; 9(1):917. PMC: 5834525. DOI: 10.1038/s41467-018-03325-6. View

Andrushchenko V, Vogel H, Prenner E . Solvent-dependent structure of two tryptophan-rich antimicrobial peptides and their analogs studied by FTIR and CD spectroscopy. Biochim Biophys Acta. 2006; 1758(10):1596-608. DOI: 10.1016/j.bbamem.2006.07.013. View

Bottger R, Hoffmann R, Knappe D . Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum. PLoS One. 2017; 12(6):e0178943. PMC: 5456363. DOI: 10.1371/journal.pone.0178943. View

Matsuzaki K, Murase O, Fujii N, Miyajima K . An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry. 1996; 35(35):11361-8. DOI: 10.1021/bi960016v. View

Yang S, Shin S, Kim J . Interaction mode of a symmetric Trp-rich undeca peptide PST11-RK with lipid bilayers. FEBS Lett. 2006; 581(1):157-63. DOI: 10.1016/j.febslet.2006.12.003. View

Berthold N, Czihal P, Fritsche S, Sauer U, Schiffer G, Knappe D . Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother. 2012; 57(1):402-9. PMC: 3535932. DOI: 10.1128/AAC.01923-12. View

Deslouches B, Hasek M, Craigo J, Steckbeck J, Montelaro R . Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine. J Med Microbiol. 2016; 65(6):554-565. PMC: 5042116. DOI: 10.1099/jmm.0.000258. View

Karstad R, Isaksen G, Wynendaele E, Guttormsen Y, De Spiegeleer B, Brandsdal B . Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration. J Med Chem. 2012; 55(14):6294-305. DOI: 10.1021/jm3002058. View

10.

Ludtke S, He K, Heller W, Harroun T, Yang L, Huang H . Membrane pores induced by magainin. Biochemistry. 1996; 35(43):13723-8. DOI: 10.1021/bi9620621. View

11.

Haney E, Petersen A, Lau C, Jing W, Storey D, Vogel H . Mechanism of action of puroindoline derived tryptophan-rich antimicrobial peptides. Biochim Biophys Acta. 2013; 1828(8):1802-13. DOI: 10.1016/j.bbamem.2013.03.023. View

12.

Chan D, Prenner E, Vogel H . Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta. 2006; 1758(9):1184-202. DOI: 10.1016/j.bbamem.2006.04.006. View

13.

Muhle S, Tam J . Design of Gram-negative selective antimicrobial peptides. Biochemistry. 2001; 40(19):5777-85. DOI: 10.1021/bi0100384. View

14.

Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

15.

Zasloff M . Antimicrobial peptides of multicellular organisms. Nature. 2002; 415(6870):389-95. DOI: 10.1038/415389a. View

16.

Schmidt N, Wong G . Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering. Curr Opin Solid State Mater Sci. 2014; 17(4):151-163. PMC: 4000235. DOI: 10.1016/j.cossms.2013.09.004. View

17.

Subbalakshmi C, Sitaram N . Mechanism of antimicrobial action of indolicidin. FEMS Microbiol Lett. 1998; 160(1):91-6. DOI: 10.1111/j.1574-6968.1998.tb12896.x. View

18.

Gentilucci L, De Marco R, Cerisoli L . Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des. 2010; 16(28):3185-203. DOI: 10.2174/138161210793292555. View

19.

Jenssen H, Hamill P, Hancock R . Peptide antimicrobial agents. Clin Microbiol Rev. 2006; 19(3):491-511. PMC: 1539102. DOI: 10.1128/CMR.00056-05. View

20.

Palermo E, Vemparala S, Kuroda K . Cationic spacer arm design strategy for control of antimicrobial activity and conformation of amphiphilic methacrylate random copolymers. Biomacromolecules. 2012; 13(5):1632-41. DOI: 10.1021/bm300342u. View